InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Explore the detailed record of transactions filed by KIRK RANDAL J, Director. Insider active across 2 companies, notably Precigen, INC.. Cumulatively, 12 filings have been logged. Total volume traded: €19.7m. The latest transaction was filed on 25 March 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations12 total
032,425 shares0
Common Stock
SEC:0001567619-22-007614:0·
€88,42049,261 shares@ €1.79490.0056% mcap4.2% of flow
Common Stock
SEC:0001567619-22-005526:0·
3,444 shares
Common Stock
SEC:0001567619-22-000657·
3,444 shares
Common Stock
SEC:0001567619-22-000657:0·
€9m4,742,552 shares@ €1.868100.0% of flow
Common Stock
SEC:0001567619-21-021154·
€9m4,742,552 shares@ €1.86850.0% of flow
Common Stock
SEC:0001567619-21-021154:0·
€1m307,661 shares@ €3.29860.064% mcap100.0% of flow
Common Stock
SEC:0001567619-21-021122·
Ideal exit: 16 Aug 2022 (T+270)
€1m307,661 shares@ €3.29860.064% mcap47.9% of flow
Common Stock
SEC:0001567619-21-021122:0·
Ideal exit: 16 Aug 2022 (T+270)
53,571 shares
Common Stock
SEC:0001567619-21-017572·
53,571 shares
Common Stock
SEC:0001567619-21-017572:0·
354,557 shares
Common Stock
SEC:0001567619-21-011765·
354,557 shares
Common Stock
SEC:0001567619-21-011765:0·
12 of 12 declarations
About KIRK RANDAL J
Randal J. Kirk is a Director at Precigen, Inc. and AquaBounty Technologies, Inc. In this role, he brings his expertise in governance and corporate strategy. His experience in the biopharmaceutical sector allows him to effectively contribute to strategic decisions and the direction of these companies.
